Pantoprazol Farmoz (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Farmoz, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Farmoz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and prevents further damage. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens (as adjunct): enhances ulcer healing when combined with antibiotics.

Pantoprazol Farmoz may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea or abdominal discomfort: occasional. - Flatulence: mild bloating. - Constipation: infrequent. - Dry mouth: occasional.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated colitis: may present with watery diarrhoea. - Acute interstitial nephritis: renal function monitoring recommended. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmia. - Fracture risk with long‑term use: especially hip, wrist or spine fractures. - Liver enzyme elevation: monitor in patients with hepatic impairment.

Before initiating Pantoprazol Farmoz, consider the following safety measures: - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review long‑term use: monitor bone health if therapy exceeds one year. - Check for drug interactions: especially with antiplatelet agents or warfarin. - Pregnancy and lactation: prescribe only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Pantoprazol Farmoz can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption; avoid concurrent use. - Atazanavir or nelfinavir: markedly decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Clopidogrel: diminished antiplatelet effect; consider alternative therapy. - Warfarin: potential increase in INR; monitor coagulation parameters. - Digoxin: modest rise in serum levels; observe for toxicity. - Methotrexate: increased exposure, especially at high doses; monitor renal function. - Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.